← FDA Drug Approvals (Drugs@FDA)
FARXIGA
NDA · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2014-01-08
Drug application
- FDA Application #
NDA202293- Application type
- New Drug Application
- Brand name
- FARXIGA
- Generic name
- DAPAGLIFLOZIN
- Active ingredients
- DAPAGLIFLOZIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ASTRAZENECA AB
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- First approval
- 2014-01-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown